X-Message-Number: 14073 Date: Tue, 11 Jul 2000 13:56:14 -0600 From: Linda Chamberlain <> Subject: FM-2030 placed into cryostasis News Release: For additional information contact Linda Chamberlain, Executive Director WHY BE PART OF THE LAST GENERATION TO DIE BEFORE ANTI-AGING MEDICINE SOLVES THE AGING PROBLEM? FOR IMMEDIATE RELEASE Scottsdale, AZ, 11 July 2000. Futurist, lecturer and writer FM-2030 was placed into cryostasis on July 10, 2000 at the Alcor Life Extension Foundation in Scottsdale, Arizona. FM-2030 was a strong advocate (for three decades) of using cryostasis as a possible means for saving the lives of individuals who cannot be saved by current medical technology. His books include The Upwingers, Optimum One, Telespheres, and Are You Transhuman?. He taught futurist classes over the years at such locations as UCLA and the Smithsonian Institution, and he wrote articles for major news papers like the New York Times and the Los Angeles Times. New surgical techniques being pioneered at Alcor were used for the first time in the cryoprotection operation for FM-2030. These resulted in vastly improved cryoprotection for this long-time supporter of the cryostasis process as a potentially life saving, though still experimental, technique. The Alcor Life Extension Foundation was founded in 1972 as a non-profit, tax-exempt 501(c)(3) organization, and has 39 patients in cryostasis. Alcor is the world's largest provider of professional cryotransport services with over 500 members who have pre-arranged for cryotransport. Alcor's Emergency CryoTransport System (ECS) is a medical-style rescue network patterned after Emergency Medical System (EMS). Alcor CryoTransport Technicians, as with EMS technicians, are remotely advised by on-call physicians who are Alcor members and/or contract physicians. If an individual is successfully placed into cryostasis, there are patient funds for long term care. These funds are maintained in an independent Patient Care Trust and are invested such that they have traditionally earned at least double the current costs of keeping patients in cryostasis, providing extra safety margin against poor investment years. Can patients in cryostasis be successfully resuscitated, perhaps decades from now, when new medical breakthroughs can reverse the damage caused by diseases not currently curable? The medical and scientific foundations for this are discussed at length in a new book: Nanomedicine, Volume I, by Robert Freitas. These revolutionary concepts were presented by Ralph Merkle, PhD at the Fourth Alcor Conference on Life Extension Technologies held in June 2000. For more information on the Alcor Life Extension Foundation, see our website at <http://www.alcor.org/>www.alcor.org ### Rate This Message: http://www.cryonet.org/cgi-bin/rate.cgi?msg=14073